Vasovagal Syncope: To Pace or not to Pace?

  • R. S. Sheldon
Conference paper


Most patients with vasovagal syncope faint infrequently and require only reassurance and advice about dietary and lifestyle modifications. However, there is a minority of patients who are considerably more distressed. Patients with recurrent vasovagal syncope may seriously injure themselves, may not be able to drive a car or to perform their jobs, and have a significant drop in objectively measured quality of life [1].


Vasovagal Syncope Orthostatic Tolerance Tilt Table Test Neurocardiogenic Syncope Permanent Pace 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rose S, Koshman M, McDonald S, Sheldon R (1996) Health-related quality of life in patients with neuromediated syncope. Can J Cardiol 12:13IE (abstr)Google Scholar
  2. 2.
    Sheldon RS (1995) What do we know today about the outcome of vasovagal syncope? In: Raviele A (ed) Cardiac Arrhythmias 1995. Springer, New York Berlin Heidelberg, pp 122–126Google Scholar
  3. 3.
    Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S (1996) Risk factors for syncope recurrence after a positive tilt table test in patients with syncope. Circulation 93:973–981PubMedCrossRefGoogle Scholar
  4. 4.
    Malik P, Koshman ML, Sheldon RS (1997) Timing of first syncope recurrence predicts syncope frequency following a positive tilt table test. J Am Coll Cardiol 29:1284–1289PubMedCrossRefGoogle Scholar
  5. 5.
    El-Sayed H, Hainsworth R (1996) Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75:134–140PubMedCrossRefGoogle Scholar
  6. 6.
    Mangru NN, Young ML, Mas MS, Chandar JS, Pearse, LA, Wolff GS (1996) Usefulness of tilt table test with normal saline infusion in management of neurocardiogenic syncope in children. Am Heart J 131:953–955PubMedCrossRefGoogle Scholar
  7. 7.
    Scott WA, Giacomo P, Bromberg BI, Schaffer MS, Deal BJ, Fish FA, Dick M (1995) Randomised comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76:400–402PubMedCrossRefGoogle Scholar
  8. 8.
    Grubb BP, Temesy-Armos P, Moore J, Wolfe D, Hahn H, Elliot L (1992) The use of head-upright tilt table testing in the evaluation and management of syncope in children and adolescents. Pacing Clin Electrophysiol 15:742–748PubMedCrossRefGoogle Scholar
  9. 9.
    Balaji S, Oslizlok PC, Allen MC, McKay CA, Gillette PC (1994) Neurocardiogenic syncope in children with a normal heart. J Am Coll Cardiol 23:779–785PubMedCrossRefGoogle Scholar
  10. 10.
    Giada F, Raviele A, Brignole M, Sutton R, Alboni P, Giani P, Menozzi C, Moya A (1999) Effect of etilefrine in preventing syncopal spells in patients with recurrent vasovagal syncope: a double-blind, randomized trial. J Am Coll Cardiol 33:269AGoogle Scholar
  11. 11.
    Natale A, Beheiry S, Tomassoni GF, Leonelli FM, Pisano E, Fanelli R, Zimmerman L, Kim VH (1999) Randomized placebo control assessment of midodrine in the treatment of neurocardiogenic syncope. J Am Coll Cardiol 33:269AGoogle Scholar
  12. 12.
    Cox MM, Perlman BA, Mayor MR, Silberstein TA, Levin E, Pringle L, Castellanos A, Myerburg R (1995) Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 26:1293–1298PubMedCrossRefGoogle Scholar
  13. 13.
    Sheldon RS, Rose S, Flanagan P, Koshman ML, Killam S (1997) Effect of beta blockers on the clinical outcome of patients after a positive isoproterenol-tilt table test. Am J Cardiol 78:536–539CrossRefGoogle Scholar
  14. 14.
    Mahanonda N, Bhuripanyo K, Kangkagate C, Wansanit K, Kulchot B, Nademanee K, Chaithiraphan S (1995) Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 130:1250–1253PubMedCrossRefGoogle Scholar
  15. 15.
    Derives LS, Fisch C, Griffin JC, Gillette PC, Mason JW, Parsonnet V (1991) Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Procedures (Committee on Pacemaker Implantation). J Am Coll Cardiol 18:1–13CrossRefGoogle Scholar
  16. 16.
    Clarke M, Sutton R, Ward D, Camm AJ, Rickards A, Ingram A, Perrins EJ, Charles R, Jones S, Cobbe S (1991) Recommendations for pacemaker prescriptions for symptomatic bradycardia. British Pacing and Electrophysiology Group Working Party report. Br Heart J 66:185–191CrossRefGoogle Scholar
  17. 17.
    Benditt DG, Petersen M, Lurie KG, Grubb BP, Sutton R (1995) Cardiac pacing for the prevention of recurrent vasovagal syncope. Ann Intern Med 122:204–209PubMedGoogle Scholar
  18. 18.
    Petersen MEV, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R (1994) Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 71:274–281PubMedCrossRefGoogle Scholar
  19. 19.
    Benditt DG, Sutton R, Gammage M, Fetter J, Markowitz T and the Rate-drop Response Investigators (1997) Clinical experience with Thera DR rate drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. Pacing Clin Electrophysiol 20:832–839PubMedCrossRefGoogle Scholar
  20. 20.
    Sheldon RS, Koshman ML, Wilson W, Kieser T, Rose S (1997) Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 81:158–162CrossRefGoogle Scholar
  21. 21.
    Connolly SJ, Sheldon RS, Roberts RS, Gent M (1999) The North American Vasovagal Pacemaker Study. A randomized trial of permanent cardiac pacemaker for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16–20PubMedCrossRefGoogle Scholar
  22. 22.
    Menozzi C, Brignole M, Lolli G, Bottoni N, Oddone D, Gianfranchi L, Gaggioli G (1993) Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker. Am J Cardiol 72:1152–1155PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • R. S. Sheldon
    • 1
  1. 1.Cardiovascular Research GroupUniversity of CalgaryCalgaryCanada

Personalised recommendations